Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Draft Pharma Policy In Trouble Again

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - India's much-delayed draft pharmaceutical policy, which was expected to be vetted by the Group of Ministers at its latest meeting on April 30, seems to have run into rough weather yet again
Advertisement

Related Content

India Health Ministry Addresses Industry Concerns About Drugs and Cosmetic Law
India Health Ministry Addresses Industry Concerns About Drugs and Cosmetic Law
India Creates New Department Of Pharmaceuticals To Coordinate Industry Regulation
India Creates New Department Of Pharmaceuticals To Coordinate Industry Regulation
Pressure Rises To Pass India’s Draft Drug Policy
Pressure Rises To Pass India’s Draft Drug Policy
Advertisement
UsernamePublicRestriction

Register

SC068655

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel